Skip to main
ADGM

ADGM Earnings Dates & Reports

ADGM Most Recent Earnings

Report Date
Period EndingQ1 2026
Est. EPS-$0.30
Actual EPS-$0.31
EarningsMiss

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

ADGM Earnings per Share (EPS) History

Signup for full access
Browse free

ADGM Latest Earnings

The value each ADGM share was expected to gain vs. the value each share gained.

ADGM reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of -$0.31. This exceeded analysts' expectations of -$0.30 by 3.33%, marking a Miss.

For comparison, Adagio Medical Holdings Inc reported EPS of $0 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.32.

ADGM Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2026
-$0.32
Q1 2026
-$0.30-$0.31+3.33%
Q4 2025
-$0.31-$0.21-32.26%
Q3 2025
-$0.66
Q2 2025
-$0.35

ADGM Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the Adagio Medical Holdings Inc’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

ADGM Earnings FAQs

ADGM last reported earnings on May 12, 2026 for Q1 2026, posting an EPS of -$0.31, which Miss the estimate of -$0.30 by 3.33%.

For Q1 2026, ADGM reported an EPS of -$0.31, missing analysts' estimate of -$0.30 by 3.33%.

For Q1 2026, ADGM Miss expectations with an actual EPS of -$0.31 vs. an estimated EPS of -$0.30.

Following the last earnings report on May 12, 2026, ADGM's stock price moved — from — to —.

The next ADGM earnings call is scheduled for Aug. 12, 2026, where executives will discuss financial results and outlook.

Adagio Medical Holdings Inc (ADGM)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.